ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors

Luigi Fattore; Debora Malpicci; Emanuele Marra; Rosalba Camerlingo; Giuseppe Roscilli; Francesca Belleudi; Antoni Ribas; Rita Mancini; Maria Rosaria Torrisi; Luigi Aurisicchio; Paolo Antonio Ascierto; Gennaro Ciliberto

doi:10.1186/1479-5876-13-S1-K3

ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors

Luigi Fattore, Debora Malpicci, Emanuele Marra, Rosalba Camerlingo, Giuseppe Roscilli, Francesca Belleudi, Antoni Ribas, Rita Mancini, Maria Rosaria Torrisi, Luigi Aurisicchio, Paolo Antonio Ascierto, Gennaro Ciliberto

Istituto Nazionale Tumori Fondazione G. Pascale

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	1-2
Number of pages	2
Journal	Journal of Translational Medicine
DOIs	https://doi.org/10.1186/1479-5876-13-S1-K3
Publication status	Accepted/In press - Jan 15 2015

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)
Medicine(all)

Cite this

Fattore, L., Malpicci, D., Marra, E., Camerlingo, R., Roscilli, G., Belleudi, F., Ribas, A., Mancini, R., Torrisi, M. R., Aurisicchio, L., Ascierto, P. A., & Ciliberto, G. (Accepted/In press). ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors. Journal of Translational Medicine, 1-2. https://doi.org/10.1186/1479-5876-13-S1-K3

ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors. / Fattore, Luigi; Malpicci, Debora; Marra, Emanuele; Camerlingo, Rosalba; Roscilli, Giuseppe; Belleudi, Francesca; Ribas, Antoni; Mancini, Rita; Torrisi, Maria Rosaria; Aurisicchio, Luigi; Ascierto, Paolo Antonio ; Ciliberto, Gennaro.

In: Journal of Translational Medicine, 15.01.2015, p. 1-2.

Research output: Contribution to journal › Article

Fattore, Luigi ; Malpicci, Debora ; Marra, Emanuele ; Camerlingo, Rosalba ; Roscilli, Giuseppe ; Belleudi, Francesca ; Ribas, Antoni ; Mancini, Rita ; Torrisi, Maria Rosaria ; Aurisicchio, Luigi ; Ascierto, Paolo Antonio ; Ciliberto, Gennaro. / ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors. In: Journal of Translational Medicine. 2015 ; pp. 1-2.

@article{9c1f4730619a46bfa8165ad2ec002890,

title = "ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors",

author = "Luigi Fattore and Debora Malpicci and Emanuele Marra and Rosalba Camerlingo and Giuseppe Roscilli and Francesca Belleudi and Antoni Ribas and Rita Mancini and Torrisi, {Maria Rosaria} and Luigi Aurisicchio and Ascierto, {Paolo Antonio} and Gennaro Ciliberto",

year = "2015",

month = jan

day = "15",

doi = "10.1186/1479-5876-13-S1-K3",

language = "English",

pages = "1--2",

journal = "Journal of Translational Medicine",

issn = "1479-5876",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors

AU - Fattore, Luigi

AU - Malpicci, Debora

AU - Marra, Emanuele

AU - Camerlingo, Rosalba

AU - Roscilli, Giuseppe

AU - Belleudi, Francesca

AU - Ribas, Antoni

AU - Mancini, Rita

AU - Torrisi, Maria Rosaria

AU - Aurisicchio, Luigi

AU - Ascierto, Paolo Antonio

AU - Ciliberto, Gennaro

PY - 2015/1/15

Y1 - 2015/1/15

UR - http://www.scopus.com/inward/record.url?scp=84928732244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928732244&partnerID=8YFLogxK

U2 - 10.1186/1479-5876-13-S1-K3

DO - 10.1186/1479-5876-13-S1-K3

M3 - Article

SP - 1

EP - 2

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

ER -

Access to Document

10.1186/1479-5876-13-S1-K3